Outset Medical Inc. (NASDAQ: OM) reported Q2 EPS of ($0.77), $0.13 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $25.1 million versus the consensus estimate of $29.22 million.

GUIDANCE:

Outset Medical Inc. sees FY2022 revenue of $105-110 million, versus the consensus of $127.9 million.

For earnings history and earnings-related data on Outset Medical Inc. (OM) click here.

Earnings Guidance

Outset Medical Inc. (OM) to Resume Trading at 10:30 a.m.August 1, 2022 10:15 AM Outset Medical (OM) Resumes Shipment of Tablo Systems for Home Use, Reports Second Quarter 2022 Financial Results and Provides 2022 GuidanceAugust 1, 2022 10:03 AM Outset Medical Resumes Shipment of Tablo Systems for Home Use, Reports Second Quarter 2022 Financial Results and Provides 2022 GuidanceAugust 1, 2022 10:02 AM Outset Medical Inc. (OM) Halted, News PendingAugust 1, 2022 9:37 AM Cowen Reiterates Outperform Rating on Outset Medical Inc. (OM), Comments on FDA ClearanceAugust 1, 2022 8:58 AM Stifel on Outset Medical Inc. (OM): 'At Last, A Big Sigh of Relief As FDA Terms Tablo Catch-Up Filing As “Substantially-Equivalent”'August 1, 2022 8:57 AM